258 related articles for article (PubMed ID: 17656562)
1. Novel tubulin-targeting agents: anticancer activity and pharmacologic profile of epothilones and related analogues.
Fumoleau P; Coudert B; Isambert N; Ferrant E
Ann Oncol; 2007 Jul; 18 Suppl 5():v9-15. PubMed ID: 17656562
[TBL] [Abstract][Full Text] [Related]
2. Epothilones as lead structures for new anticancer drugs--pharmacology, fermentation, and structure-activity-relationships.
Altmann KH; Memmert K
Prog Drug Res; 2008; 66():273, 275-334. PubMed ID: 18416309
[TBL] [Abstract][Full Text] [Related]
3. Preclinical investigations with epothilones in breast cancer models.
Burris HA
Semin Oncol; 2008 Apr; 35(2 Suppl 2):S15-21; quiz S39. PubMed ID: 18410795
[TBL] [Abstract][Full Text] [Related]
4. Epothilones: a novel class of microtubule-stabilizing drugs for the treatment of cancer.
Trivedi M; Budihardjo I; Loureiro K; Reid TR; Ma JD
Future Oncol; 2008 Aug; 4(4):483-500. PubMed ID: 18684060
[TBL] [Abstract][Full Text] [Related]
5. Epothilones: tubulin polymerization as a novel target for prostate cancer therapy.
Lee JJ; Kelly WK
Nat Clin Pract Oncol; 2009 Feb; 6(2):85-92. PubMed ID: 19048010
[TBL] [Abstract][Full Text] [Related]
6. The epothilones: how pharmacology relates to clinical utility.
Michaud LB
Ann Pharmacother; 2009 Jul; 43(7):1294-309. PubMed ID: 19584389
[TBL] [Abstract][Full Text] [Related]
7. Targeting the microtubules in breast cancer beyond taxanes: the epothilones.
Cortes J; Baselga J
Oncologist; 2007 Mar; 12(3):271-80. PubMed ID: 17405891
[TBL] [Abstract][Full Text] [Related]
8. Preclinical discovery of ixabepilone, a highly active antineoplastic agent.
Lee FY; Borzilleri R; Fairchild CR; Kamath A; Smykla R; Kramer R; Vite G
Cancer Chemother Pharmacol; 2008 Dec; 63(1):157-66. PubMed ID: 18347795
[TBL] [Abstract][Full Text] [Related]
9. Potential clinical applications of epothilones: a review of phase II studies.
Larkin JM; Kaye SB
Ann Oncol; 2007 Jul; 18 Suppl 5():v28-34. PubMed ID: 17656559
[TBL] [Abstract][Full Text] [Related]
10. Epothilones in prostate cancer: review of clinical experience.
Dawson NA
Ann Oncol; 2007 Jul; 18 Suppl 5():v22-7. PubMed ID: 17656558
[TBL] [Abstract][Full Text] [Related]
11. Epothilones: clinical update and future directions.
Donovan D; Vahdat LT
Oncology (Williston Park); 2008 Apr; 22(4):408-16; discussion 416, 421, 424 passim. PubMed ID: 18472615
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of ixabepilone, a novel epothilone analogue.
Pivot X; Dufresne A; Villanueva C
Clin Breast Cancer; 2007 Apr; 7(7):543-9. PubMed ID: 17509162
[TBL] [Abstract][Full Text] [Related]
13. Novel microtubule-targeting agents - the epothilones.
Cheng KL; Bradley T; Budman DR
Biologics; 2008 Dec; 2(4):789-811. PubMed ID: 19707459
[TBL] [Abstract][Full Text] [Related]
14. Epothilones in breast cancer: review of clinical experience.
Fornier MN
Ann Oncol; 2007 Jul; 18 Suppl 5():v16-21. PubMed ID: 17656557
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with epothilones in patients with breast cancer.
Buzdar AU
Clin Breast Cancer; 2008 Mar; 8 Suppl 2():S71-8. PubMed ID: 18637402
[TBL] [Abstract][Full Text] [Related]
16. Synthesis & antitumor activity of epothilones B and D and their analogs.
Cheng H; Huang G
Future Med Chem; 2018 Jun; 10(12):1483-1496. PubMed ID: 29788770
[TBL] [Abstract][Full Text] [Related]
17. Development of other microtubule-stabilizer families: the epothilones and their derivatives.
Brogdon CF; Lee FY; Canetta RM
Anticancer Drugs; 2014 May; 25(5):599-609. PubMed ID: 24398663
[TBL] [Abstract][Full Text] [Related]
18. Epothilones in the treatment of cancer.
Larkin JM; Kaye SB
Expert Opin Investig Drugs; 2006 Jun; 15(6):691-702. PubMed ID: 16732719
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics of tubulin and tubulin-binding agents: extending their potential beyond taxanes.
Andreopoulou E; Muggia F
Clin Breast Cancer; 2008 Mar; 8 Suppl 2():S54-60. PubMed ID: 18637400
[TBL] [Abstract][Full Text] [Related]
20. Novel drugs targeting microtubules: the role of epothilones.
Ferrandina G; Mariani M; Andreoli M; Shahabi S; Scambia G; Ferlini C
Curr Pharm Des; 2012; 18(19):2793-803. PubMed ID: 22390763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]